Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,016 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors.
Janku F, Tsimberidou AM, Garrido-Laguna I, Wang X, Luthra R, Hong DS, Naing A, Falchook GS, Moroney JW, Piha-Paul SA, Wheler JJ, Moulder SL, Fu S, Kurzrock R. Janku F, et al. Among authors: kurzrock r. Mol Cancer Ther. 2011 Mar;10(3):558-65. doi: 10.1158/1535-7163.MCT-10-0994. Epub 2011 Jan 7. Mol Cancer Ther. 2011. PMID: 21216929 Free PMC article.
Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway.
Siwak DR, Shishodia S, Aggarwal BB, Kurzrock R. Siwak DR, et al. Among authors: kurzrock r. Cancer. 2005 Aug 15;104(4):879-90. doi: 10.1002/cncr.21216. Cancer. 2005. PMID: 16007726 Free article.
Studies in target-based treatment.
Kurzrock R. Kurzrock R. Mol Cancer Ther. 2007 May;6(5):1477. doi: 10.1158/1535-7163.MCT-07-0255. Epub 2007 May 4. Mol Cancer Ther. 2007. PMID: 17483434
Cutaneous castleman's disease responds to anti interleukin-6 treatment.
Ahmed B, Tschen JA, Cohen PR, Zaki MH, Rady PL, Tyring SK, Corringham RE, Kurzrock R. Ahmed B, et al. Among authors: kurzrock r. Mol Cancer Ther. 2007 Sep;6(9):2386-90. doi: 10.1158/1535-7163.MCT-07-0256. Epub 2007 Aug 31. Mol Cancer Ther. 2007. PMID: 17766835
Studies in target-based treatment.
Kurzrock R. Kurzrock R. Mol Cancer Ther. 2007 Sep;6(9):2385. doi: 10.1158/1535-7163.MCT-06-9S. Epub 2007 Sep 10. Mol Cancer Ther. 2007. PMID: 17846118 No abstract available.
1,016 results